FindTrial
Sign In

Nano-CoQ10 Improves the Body Immunity for Patients With Alzheimer's Disease

The Effects of Nano-CoQ10 on the Body Immunity for Patients With Alzheimer's Disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022669
Enrollment
Unknown
Registered
2019-04-21
Start date
2019-04-25
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Interventions

1:Oral Administration of Coenzyme Q10 combined with conventional treatment
2:conventional treatment

Sponsors

The Second Department of Mental Psychology in Beijing Geriatric Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who met the diagnostic criteria of dementia in accordance with the American Psychiatric Association's Manual of Psychiatric Diagnosis and Statistics (Four Edition, DSM-IV).

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Frailty Index(FI);—

Countries

China

Contacts

Public ContactZhiqian Tong

Chinese Capital Medical University

tzqbeida@163.com+86 13683373001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026